GE HealthCare (GEHC) Fundamental Analysis: Revenue, Earnings & Valuation

0.34 / 10

Underperform

Fundamental analysis rates GEHC as Underperform, scoring only 0.34/10. Cash‑MV and ROA are solid, yet profit‑related ratios such as Net profit/Total profit and Total profit/EBIT are poor, dragging overall quality to a 0.3/10 rating and urging caution.

Analysis Checks(7/10)

ROA (%)

Value6.15

Score3/3

Weight-20.94%

1M Return0.90%

Net cash flow from operating activities / Operating revenue (%)

Value9.63

Score2/3

Weight-14.06%

1M Return0.62%

Profit-MV

Value1.14

Score1/3

Weight98.83%

1M Return-5.65%

Net profit margin (%)

Value10.44

Score3/3

Weight-19.23%

1M Return0.82%

Total profit / EBIT (%)

Value86.28

Score0/3

Weight97.57%

1M Return-5.54%

Net cash flow from operating activities / Total liabilities (%)

Value0.08

Score2/3

Weight-17.74%

1M Return0.75%

Annualized net profit margin on total assets (%)

Value6.15

Score3/3

Weight-20.94%

1M Return0.90%

Asset-MV

Value-0.55

Score2/3

Weight7.01%

1M Return-0.35%

Cash-MV

Value0.39

Score2/3

Weight-67.12%

1M Return2.64%

Net profit / Total profit (%)

Value77.82

Score1/3

Weight56.63%

1M Return-3.12%

Is GEHC undervalued or overvalued?

GEHC scores 0.34/10 on fundamentals and holds a Premium valuation at present. Backed by its 21.65% ROE, 10.44% net margin, 15.54 P/E ratio, 3.05 P/B ratio, and 4.35% earnings growth, these metrics solidify its Underperform investment rating.